Search results
Novavax, Inc. (NVAX) vs. Its Peers: A Comparison – News Heater
NewsHeater· 3 days agoThere are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.” The public float for NVAX is 132.98M ...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 4 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
InvestorPlace· 1 day agoIf you have a high tolerance for volatility then the biotech sector might be for you. Biotech stocks...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 5 days agoThat could happen if Amtagvi sales truly take off, showing the potential of TIL technology. But even...
Europe Strengthens Future Disease Defense
Medscape· 8 hours agoA network of health security agencies has been established in Europe and Central Asia to bolster the region's preparedness to meet future disease...
12 Most Shorted Stocks in 2024
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, read our article 5 Most Shorted...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Zacks via Yahoo Finance· 4 days agoLNTH is just one of a large group of Medical stocks with a positive ESP figure. Novavax (NVAX) is...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 2 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 4 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
